The triad in current neuroblastoma challenges: Targeting antigens, enhancing effective cytotoxicity and accurate 3D in vitro modelling.

Transl Oncol · 2025 · PMC11565549 · PMID 39489087

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

did not find a clear trend with E:Ts of 0.3:1, 1:1, and 3:1 using engineered γδ- T cells [ 68 ].

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.